University of New Mexico
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexico sits in the top decile of US sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count).
University of New Mexico: 168 sponsored US clinical trials, 2 recruiting.
University of New Mexico sponsors 168 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 123 completed. 15 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
University of New Mexico ranks in the top decile of sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 165 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
168 total, page 1 of 4
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
NCT07506395
Trial of Underwater Birth
NCT07313319
Airway Scope vs GlideScope for Intubation in Obese Patients
NCT07453563
Cognitive Strategies for Improving Health Outcomes And Managing Risk Post-Stroke
NCT06066788
Making it Work Program for Systemic Sclerosis
NCT06338722
Resiliency in U.S. Air Force Personnel
NCT05700435
Feasibility of the ROADE Program
NCT05911334
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
NCT05298709
Social Media Navigation Aid Kits for Urinary Incontinence
NCT05858125
Move For Your Health for Older Cancer Survivors
NCT05582889
TMS Alteration of the Reward Positivity
NCT05443256
INvestigation of TENS Efficacy Versus Posterior Tibial Nerve Stimulation for Overactive Bladder
NCT05309993
Maternal Voice and Quantitative EEG (qEEG)
NCT05391633
High-intensity Interval Training for Obese Individuals
NCT04075799
Pelvic Floor Disorders Among Sexual Minoritized Women
NCT05072158
Noninvasive Modulation of Motivational Brain Regions in Healthy Volunteers
NCT04972786
Skin to Skin and Heart Rate Variability
NCT05018910
Thermal-Imaging Comparison of Nerve Blocks for Bilateral Mastectomy
NCT04928794
Electroconvulsive Therapy Amplitude Titration
NCT04621786
The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners
NCT04977050
Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement: COVID-19 Study
NCT04520191
Group B Streptococcus Response After Probiotic Exposure
NCT04721912
Improving Resiliency in Air Force Personnel
NCT05460663
Myofascial and Articular Treatment of Adolescent Idiopathic Scoliosis
NCT05423509
"Facemask Use During High-intensity Interval Exercise in Temperate and Hot Environments"
NCT05143801
Pilot of IMPACT Intervention at the University of New Mexico
NCT04166994
Evaluating the Effect of an Evidence-Based One Page With Supplemental Visual Aids on the Knowledge and Perceptions of Blood Pressure Management Among Adults With Hypertension
NCT04824560
Increasing Use of Earned Income Tax Credit (EITC) in New Mexico
NCT04961177
Tertulias Social Isolation Women's Groups Study
NCT04254198
Piloting a Motivational Interviewing Shame-Resilience Training
NCT05106959
Online Fatigue Intervention Program for People With Scleroderma
NCT04401943
Effects of the COVID-19 Health Emergency on Biopsychosocial Health
NCT04409535
Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19
NCT04434131
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19
NCT04435808
Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients
NCT04458948
Rapid HCV RNA Testing and LInkage to Care
NCT04302948
Tegarderm® Placement for Bag Mask Ventilation in the Bearded Patient
NCT04274686
Southwest Harvest for Health Vegetable Gardening Intervention
NCT04251299
Remote Assessment of Physical Function
NCT04339959
EEG Characteristics in ECT
NCT04022226
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
NCT03983421
Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures
NCT04048356
Breastfeeding Etonogestrel Implant Study
NCT03978598
Cytokine Registry Database of Stroke Patients
NCT03297827
Translational Model of Anhedonia
NCT03856177
Hirschsprung Disease Trends in the United States: Analysis of the National Inpatient Sample
NCT05038345
Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses
NCT03752307
Providing Expanded Continuous Labor Support to Pregnant Women in New Mexico With Substance Use Disorders
NCT03808909
University of New Mexico Dental Hygiene
NCT03876353
Treating Pain With Acceptance and Commitment Therapy Trial
NCT03666455
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 11 |
| Phase 3 | 4 |
| Phase 4 | 11 |
What is open in the University of New Mexico pipeline
2 recruiting of 168 indexed (1% open); 123 completed (73%).
Phase mix: 15 late (III/IV) vs 25 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexico: open-pipeline peers nationwide
Peers matched on 168 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
University of New Mexico sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 168 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Seattle Children's Hospital · 168 trials · 17% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Astellas Pharma · 1% recruiting · 165 trials
- Abbott Nutrition · 1% recruiting · 89 trials
- Baxalta now part of Shire · 1% recruiting · 74 trials
- Power Life Sciences · 2% recruiting · 62 trials
Related
What to do with this University of New Mexico page
168 registered trials is a research-attention snapshot, not an endorsement of University of New Mexico or any single study.
- 2 of University of New Mexico's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexico pipeline card: 168 registered trials from official public datasets.Report a data error.